Amlodipine/telmisartan/hydrochlorothiazide - IlDong

Drug Profile

Amlodipine/telmisartan/hydrochlorothiazide - IlDong

Alternative Names: TAH - IlDong Pharmaceutical; Telmisartan/amlodipine besylate/hydrochlorothiazide - IlDong Pharmaceutical

Latest Information Update: 01 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Il Dong
  • Class Antihypertensives; Benzimidazoles; Benzoates; Benzothiadiazines; Branched-chain amino acids; Dihydropyridines; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Thiazide diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Essential hypertension

Most Recent Events

  • 27 Dec 2016 IlDong Pharmaceutical completes a phase I pharmacokinetics trial in Healthy volunteers in South Korea (PO) (NCT03032315)
  • 01 Aug 2016 IlDong Pharmaceutical completes a phase III trial in Essential hypertension in South Korea (NCT02738632)
  • 22 Jun 2016 Chemical information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top